US › Healthcare

CryoCell International Inc (CCEL)

US · Healthcare · Medical Care Facilities

$3.56+2.30%
Last close · 2026-08-04

Latest quarter · ended 2026-05-31

Revenue
$7.8M
Revenue YoY
-1.9%
Net profit
$554,586
Profit YoY
+55.9%
EPS
$0.07
Net margin
7.1%

Key statistics

Market cap
$28.1M
Forward P/E
2,000.0
P/B
9.72
Book value
$-2.20
EPS (TTM)
$-0.31
52-week high
$5.43
52-week low
$2.72
50-day MA
$3.50
200-day MA
$3.62
Beta
0.52

Analyst view

Analysts rate CryoCell International Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.50.

Shareholding

Insiders
42.03%
Institutions
13.44%

Largest institutional holders

FundStake
SFI Advisors, LLC2.05%
Vanguard Capital Management, LLC2.01%
Vanguard Group Inc1.87%
MASSMUTUAL TRUST CO FSB/ADV1.38%
Geode Capital Management, LLC0.54%
Vanguard Fiduciary Trust Co0.29%
BlackRock Inc0.17%
Susquehanna International Group, LLP0.12%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CryoCell International Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.